Letter Regarding "Scaphocapitate Arthrodesis for Treatment of Scapholunate Instability in Manual Workers"

P. Saffar

Abstract:

What problem does this paper attempt to address?

Reliability of multi-site UK Biobank MRI brain phenotypes for the assessment of neuropsychiatric complications of SARS-CoV-2 infection: The COVID-CNS travelling heads study

Eugene Duff,Fernando Zelaya,Fidel Alfaro Almagro,Karla L Miller,Naomi Martin,Thomas E Nichols,Bernd Taschler,Ludovica Griffanti,Christoph Arthofer,Gwenaëlle Douaud,Chaoyue Wang,Thomas W Okell,Richard A I Bethlehem,Klaus Eickel,Matthias Günther,David K Menon,Guy Williams,Bethany Facer,David J Lythgoe,Flavio Dell'Acqua,Greta K Wood,Steven C R Williams,Gavin Houston,Simon S Keller,Catherine Holden,Monika Hartmann,Lily George,Gerome Breen,Benedict D Michael,Peter Jezzard,Stephen M Smith,Edward T Bullmore,COVID-CNS Consortium

DOI: https://doi.org/10.1371/journal.pone.0273704

IF: 3.7

2022-09-29

PLoS ONE

Abstract:Introduction: Magnetic resonance imaging (MRI) of the brain could be a key diagnostic and research tool for understanding the neuropsychiatric complications of COVID-19. For maximum impact, multi-modal MRI protocols will be needed to measure the effects of SARS-CoV-2 infection on the brain by diverse potentially pathogenic mechanisms, and with high reliability across multiple sites and scanner manufacturers. Here we describe the development of such a protocol, based upon the UK Biobank, and its validation with a travelling heads study. A multi-modal brain MRI protocol comprising sequences for T1-weighted MRI, T2-FLAIR, diffusion MRI (dMRI), resting-state functional MRI (fMRI), susceptibility-weighted imaging (swMRI), and arterial spin labelling (ASL), was defined in close approximation to prior UK Biobank (UKB) and C-MORE protocols for Siemens 3T systems. We iteratively defined a comparable set of sequences for General Electric (GE) 3T systems. To assess multi-site feasibility and between-site variability of this protocol, N = 8 healthy participants were each scanned at 4 UK sites: 3 using Siemens PRISMA scanners (Cambridge, Liverpool, Oxford) and 1 using a GE scanner (King's College London). Over 2,000 Imaging Derived Phenotypes (IDPs), measuring both data quality and regional image properties of interest, were automatically estimated by customised UKB image processing pipelines (S2 File). Components of variance and intra-class correlations (ICCs) were estimated for each IDP by linear mixed effects models and benchmarked by comparison to repeated measurements of the same IDPs from UKB participants. Intra-class correlations for many IDPs indicated good-to-excellent between-site reliability. Considering only data from the Siemens sites, between-site reliability generally matched the high levels of test-retest reliability of the same IDPs estimated in repeated, within-site, within-subject scans from UK Biobank. Inclusion of the GE site resulted in good-to-excellent reliability for many IDPs, although there were significant between-site differences in mean and scaling, and reduced ICCs, for some classes of IDP, especially T1 contrast and some dMRI-derived measures. We also identified high reliability of quantitative susceptibility mapping (QSM) IDPs derived from swMRI images, multi-network ICA-based IDPs from resting-state fMRI, and olfactory bulb structure IDPs from T1, T2-FLAIR and dMRI data. Conclusion: These results give confidence that large, multi-site MRI datasets can be collected reliably at different sites across the diverse range of MRI modalities and IDPs that could be mechanistically informative in COVID brain research. We discuss limitations of the study and strategies for further harmonisation of data collected from sites using scanners supplied by different manufacturers. These acquisition and analysis protocols are now in use for MRI assessments of post-COVID patients (N = 700) as part of the ongoing COVID-CNS study.
Computerised cognitive assessment in patients with traumatic brain injury: an observational study of feasibility and sensitivity relative to established clinical scales

Martina Del Giovane,William R Trender,Maria Bălăeţ,Emma-Jane Mallas,Amy E Jolly,Niall J Bourke,Karl Zimmermann,Neil S N Graham,Helen Lai,Ethan J F Losty,Garazi Araña Oiarbide,Peter J Hellyer,Irene Faiman,Sarah J C Daniels,Philippa Batey,Matthew Harrison,Valentina Giunchiglia,Magdalena A Kolanko,Michael C B David,Lucia M Li,Célia Demarchi,Daniel Friedland,David J Sharp,Adam Hampshire

DOI: https://doi.org/10.1016/j.eclinm.2023.101980

IF: 15.1

2023-04-27

EClinicalMedicine

Abstract:Background: Online technology could potentially revolutionise how patients are cognitively assessed and monitored. However, it remains unclear whether assessments conducted remotely can match established pen-and-paper neuropsychological tests in terms of sensitivity and specificity. Methods: This observational study aimed to optimise an online cognitive assessment for use in traumatic brain injury (TBI) clinics. The tertiary referral clinic in which this tool has been clinically implemented typically sees patients a minimum of 6 months post-injury in the chronic phase. Between March and August 2019, we conducted a cross-group, cross-device and factor analyses at the St. Mary's Hospital TBI clinic and major trauma wards at Imperial College NHS trust and St. George's Hospital in London (UK), to identify a battery of tasks that assess aspects of cognition affected by TBI. Between September 2019 and February 2020, we evaluated the online battery against standard face-to-face neuropsychological tests at the Imperial College London research centre. Canonical Correlation Analysis (CCA) determined the shared variance between the online battery and standard neuropsychological tests. Finally, between October 2020 and December 2021, the tests were integrated into a framework that automatically generates a results report where patients' performance is compared to a large normative dataset. We piloted this as a practical tool to be used under supervised and unsupervised conditions at the St. Mary's Hospital TBI clinic in London (UK). Findings: The online assessment discriminated processing-speed, visual-attention, working-memory, and executive-function deficits in TBI. CCA identified two significant modes indicating shared variance with standard neuropsychological tests (r = 0.86, p < 0.001 and r = 0.81, p = 0.02). Sensitivity to cognitive deficits after TBI was evident in the TBI clinic setting under supervised and unsupervised conditions (F (15,555) = 3.99; p < 0.001). Interpretation: Online cognitive assessment of TBI patients is feasible, sensitive, and efficient. When combined with normative sociodemographic models and autogenerated reports, it has the potential to transform cognitive assessment in the healthcare setting. Funding: This work was funded by a National Institute for Health Research (NIHR) Invention for Innovation (i4i) grant awarded to DJS and AH (II-LB-0715-20006).
[The influence of intrahepatic transplantation of hepatocytes and insular cells on liver cirrhosis].

Y. Wang,J. Xue,Z. Zhang,Y. Zhou

1998-03-01

Abstract:OBJECTIVE To protect liver function, we used the cirrhotic rats to study whether the postshunt intrahepatic transplantation of hepatocytes and insular cells via hepatic artery can improve liver function. METHOD We irrigated the cirrhotic liver of rat via hepatic artery with hepatocytes and insular cells and observed the influence of this method on liver function. RESULT The improvement of TP, ALB and TBIL in the experimental group were significant, and there was significant difference in these parameters between the experimental and control groups (P < 0.01). Light microscopic examination of liver fibrosis and immunohistochemistry and data analysis of I, II collagens also showed significant difference (P < 0.05). CONCLUSION The intrahepatic transplantation of hepatocytes and insular cells via hepatic artery can not only improve liver function, but also increase the degradation of liver collagens and reverse the course of liver cirrhosis.
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Ross W Paterson,for the UCL Queen Square National Hospital for Neurology and Neurosurgery COVID-19 Study Group,Rachel L Brown,Laura Benjamin,Ross Nortley,Sarah Wiethoff,Tehmina Bharucha,Dipa L Jayaseelan,Kumar,Rhian E Raftopoulos,Laura Zambreanu,Vinojini Vivekanandam,Anthony Khoo,Ruth Geraldes,Krishna Chinthapalli,Elena Boyd,Hatice Tuzlali,Gary Price,Gerry Christofi,Jasper Morrow,Patricia McNamara,Benjamin McLoughlin,Soon Tjin Lim,Puja R Mehta,Viva Levee,Stephen Keddie,Wisdom Yong,S Anand Trip,Alexander J M Foulkes,Gary Hotton,Thomas D Miller,Alex D Everitt,Christopher Carswell,Nicholas W S Davies,Michael Yoong,David Attwell,Jemeen Sreedharan,Eli Silber,Jonathan M Schott,Arvind Chandratheva,Richard J Perry,Robert Simister,Anna Checkley,Nicky Longley,Simon F Farmer,Francesco Carletti,Catherine Houlihan,Maria Thom,Michael P Lunn,Jennifer Spillane,Robin Howard,Angela Vincent,David J Werring,Chandrashekar Hoskote,Hans Rolf Jäger,Hadi Manji,Michael S Zandi,Guru Kumar

DOI: https://doi.org/10.1093/brain/awaa240

IF: 14.5

2020-07-08

Brain

Abstract:Abstract Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19) neurology multi-disciplinary meeting was established at the National Hospital, Queen Square, in early March 2020 in order to discuss and begin to understand neurological presentations in patients with suspected COVID-19-related neurological disorders. Detailed clinical and paraclinical data were collected from cases where the diagnosis of COVID-19 was confirmed through RNA PCR, or where the diagnosis was probable/possible according to World Health Organization criteria. Of 43 patients, 29 were SARS-CoV-2 PCR positive and definite, eight probable and six possible. Five major categories emerged: (i) encephalopathies (n = 10) with delirium/psychosis and no distinct MRI or CSF abnormalities, and with 9/10 making a full or partial recovery with supportive care only; (ii) inflammatory CNS syndromes (n = 12) including encephalitis (n = 2, para- or post-infectious), acute disseminated encephalomyelitis (n = 9), with haemorrhage in five, necrosis in one, and myelitis in two, and isolated myelitis (n = 1). Of these, 10 were treated with corticosteroids, and three of these patients also received intravenous immunoglobulin; one made a full recovery, 10 of 12 made a partial recovery, and one patient died; (iii) ischaemic strokes (n = 8) associated with a pro-thrombotic state (four with pulmonary thromboembolism), one of whom died; (iv) peripheral neurological disorders (n = 8), seven with Guillain-Barré syndrome, one with brachial plexopathy, six of eight making a partial and ongoing recovery; and (v) five patients with miscellaneous central disorders who did not fit these categories. SARS-CoV-2 infection is associated with a wide spectrum of neurological syndromes affecting the whole neuraxis, including the cerebral vasculature and, in some cases, responding to immunotherapies. The high incidence of acute disseminated encephalomyelitis, particularly with haemorrhagic change, is striking. This complication was not related to the severity of the respiratory COVID-19 disease. Early recognition, investigation and management of COVID-19-related neurological disease is challenging. Further clinical, neuroradiological, biomarker and neuropathological studies are essential to determine the underlying pathobiological mechanisms that will guide treatment. Longitudinal follow-up studies will be necessary to ascertain the long-term neurological and neuropsychological consequences of this pandemic.

neurosciences,clinical neurology
Late results of valvoplasty for mitral regurgitation due to rupture of chordae tendineae of posterior cusp.

B. Ross,A. Brown,C. Fox,M. Webb-peploe,M. Braimbridge

1973-05-01

Abstract:
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients

Denise Battaglini,Gregorio Santori,Karthikka Chandraptham,Francesca Iannuzzi,Matilde Bastianello,Fabio Tarantino,Lorenzo Ball,Daniele Roberto Giacobbe,Antonio Vena,Matteo Bassetti,Matilde Inglese,Antonio Uccelli,Patricia Rieken Macedo Rocco,Nicolò Patroniti,Iole Brunetti,Paolo Pelosi,Chiara Robba

DOI: https://doi.org/10.3389/fneur.2020.602114

IF: 3.4

2020-11-27

Frontiers in Neurology

Abstract:Purpose: The incidence and the clinical presentation of neurological manifestations of coronavirus disease-2019 (COVID-19) remain unclear. No data regarding the use of neuromonitoring tools in this group of patients are available. Methods: This is a retrospective study of prospectively collected data. The primary aim was to assess the incidence and the type of neurological complications in critically ill COVID-19 patients and their effect on survival as well as on hospital and intensive care unit (ICU) length of stay. The secondary aim was to describe cerebral hemodynamic changes detected by noninvasive neuromonitoring modalities such as transcranial Doppler, optic nerve sheath diameter (ONSD), and automated pupillometry. Results: Ninety-four patients with COVID-19 admitted to an ICU from February 28 to June 30, 2020, were included in this study. Fifty-three patients underwent noninvasive neuromonitoring. Neurological complications were detected in 50% of patients, with delirium as the most common manifestation. Patients with neurological complications, compared to those without, had longer hospital (36.8 ± 25.1 vs. 19.4 ± 16.9 days, p < 0.001) and ICU (31.5 ± 22.6 vs. 11.5±10.1 days, p < 0.001) stay. The duration of mechanical ventilation was independently associated with the risk of developing neurological complications (odds ratio 1.100, 95% CI 1.046–1.175, p = 0.001). Patients with increased intracranial pressure measured by ONSD (19% of the overall population) had longer ICU stay. Conclusions: Neurological complications are common in critically ill patients with COVID-19 receiving invasive mechanical ventilation and are associated with prolonged ICU length of stay. Multimodal noninvasive neuromonitoring systems are useful tools for the early detection of variations in cerebrovascular parameters in COVID-19.

neurosciences,clinical neurology
The National Institutes of Health COVID-19 Neuro Databank/Biobank: Creation and Evolution

Sharon B. Meropol,Cecile J. Norris,Jennifer A. Frontera,Adenike Adeagbo,Andrea B. Troxel,

DOI: https://doi.org/10.1159/000539830

2024-06-26

Neuroepidemiology

Abstract:Introduction Diverse neurological conditions are reported associated with the SARS-CoV-2 virus; neurological symptoms are the most common conditions to persist after resolution of acute infection, affecting 20% of patients six months after acute illness. The COVID-19 Neuro Databank (NeuroCOVID) was created to overcome the limitations of siloed small local cohorts to collect detailed, curated, and harmonized de-identified data from a large diverse cohort of adults with new or worsened neurological conditions associated with COVID-19 illness, as a scientific resource. Methods A Steering Committee including U.S. and international experts meets quarterly to provide guidance. Initial study sites were recruited to include a wide U.S. geographic distribution, academic and non-academic sites, urban and non-urban locations, and patients of different ages, disease severity, and comorbidities seen by a variety of clinical specialists. The NeuroCOVID REDCap database was developed, incorporating input from professional guidelines, existing common data elements, and subject matter experts. A cohort of eligible adults is identified at each site; inclusion criteria are: a new or worsened neurological condition associated with a COVID-19 infection confirmed by testing. De-identified data are abstracted from patients’ medical records, using standardized common data elements and five case report forms. The database was carefully enhanced in response to feedback from site investigators and evolving scientific interest in post-acute conditions and their timing. Additional U.S. and international sites were added, focusing on diversity and populations not already described in published literature. By early 2024, NeuroCOVID included over 2700 patient records, including data from 16 U.S. and 5 international sites. Data are being shared with the scientific community in compliance with NIH requirements. The program has been invited to share case report forms with the National Library of Medicine as an ongoing resource for the scientific community. Conclusion The NeuroCOVID database is a unique and valuable source of comprehensive de-identified data on a wide variety of neurological conditions associated with COVID-19 illness, including a diverse patient population. Initiated early in the pandemic, data collection has been responsive to evolving scientific interests. NeuroCOVID will continue to contribute to scientific efforts to characterize and treat this challenging illness and its consequences.

public, environmental & occupational health,clinical neurology
Conducting an objective structured clinical examination under COVID-restricted conditions

Andrea Gotzmann,John Boulet,Yichi Zhang,Judy McCormick,Mathieu Wojcik,Ilona Bartman,Debra Pugh

DOI: https://doi.org/10.1186/s12909-024-05774-8

2024-07-25

Abstract:Background: The administration of performance assessments during the coronavirus disease of 2019 (COVID-19) pandemic posed many challenges, especially for examinations employed as part of certification and licensure. The National Assessment Collaboration (NAC) Examination, an Objective Structured Clinical Examination (OSCE), was modified during the pandemic. The purpose of this study was to gather evidence to support the reliability and validity of the modified NAC Examination. Methods: The modified NAC Examination was delivered to 2,433 candidates in 2020 and 2021. Cronbach's alpha, decision consistency, and accuracy values were calculated. Validity evidence includes comparisons of scores and sub-scores for demographic groups: gender (male vs. female), type of International Medical Graduate (IMG) (Canadians Studying Abroad (CSA) vs. non-CSA), postgraduate training (PGT) (no PGT vs. PGT), and language of examination (English vs. French). Criterion relationships were summarized using correlations within and between the NAC Examination and the Medical Council of Canada Qualifying Examination (MCCQE) Part I scores. Results: Reliability estimates were consistent with other OSCEs similar in length and previous NAC Examination administrations. Both total score and sub-score differences for gender were statistically significant. Total score differences by type of IMG and PGT were not statistically significant, but sub-score differences were statistically significant. Administration language was not statistically significant for either the total scores or sub-scores. Correlations were all statistically significant with some relationships being small or moderate (0.20 to 0.40) or large (> 0.40). Conclusions: The NAC Examination yields reliable total scores and pass/fail decisions. Expected differences in total scores and sub-scores for defined groups were consistent with previous literature, and internal relationships amongst NAC Examination sub-scores and their external relationships with the MCCQE Part I supported both discriminant and criterion-related validity arguments. Modifications to OSCEs to address health restrictions can be implemented without compromising the overall quality of the assessment. This study outlines some of the validity and reliability analyses for OSCEs that required modifications due to COVID.
Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

Seth N. Levin,Shruthi Venkatesh,Katie E. Nelson,Yi Li,Ines Aguerre,Wen Zhu,Karman Masown,Kathryn T. Rimmer,Claudiu I. Diaconu,Kaho B. Onomichi,Victoria M. Leavitt,Libby L. Levine,Rebecca Strauss‐Farber,Wendy S. Vargas,Brenda Banwell,Amit Bar‐Or,Joseph R. Berger,Andrew D. Goodman,Erin E. Longbrake,Jiwon Oh,Bianca Weinstock‐Guttman,Kiran T. Thakur,Keith R. Edwards,Claire S. Riley,Zongqi Xia,Philip L. De Jager,Multiple Sclerosis Resilience to COVID‐19 Collaborative,

DOI: https://doi.org/10.1002/acn3.51314

IF: 5.43

2021-02-22

Annals of Clinical and Translational Neurology

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To report initial results of a planned multicenter year‐long prospective study examining the risk and impact of COVID‐19 among persons with neuroinflammatory disorders (NID), particularly multiple sclerosis (MS).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>In April 2020, we deployed online questionnaires to individuals in their home environment to assess the prevalence and potential risk factors of suspected COVID‐19 in persons with NID (PwNID) and change in their neurological care.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Our cohort included 1115 participants (630 NID, 98% MS; 485 reference) as of 30 April 2020. 202 (18%) participants, residing in areas with high COVID‐19 case prevalence, met the April 2020 CDC symptom criteria for suspected COVID‐19, but only 4% of all participants received testing given testing shortages. Among all participants, those with suspected COVID‐19 were younger, more racially diverse, and reported more depression and liver disease. PwNID had the same rate of suspected COVID‐19 as the reference group. Early changes in disease management included telemedicine visits in 21% and treatment changes in 9% of PwNID. After adjusting for potential confounders, increasing neurological disability was associated with a greater likelihood of suspected COVID‐19 (OR<sub>adj</sub> = 1.45, 1.17–1.84). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Interpretations</h3><p>Our study of real‐time, patient‐reported experience during the COVID‐19 pandemic complements physician‐reported MS case registries which capture an excess of severe cases. Overall, PwNID seem to have a risk of suspected COVID‐19 similar to the reference population.</p></section>

neurosciences,clinical neurology
Neuroimaging of neuropsychological disturbances following ischaemic stroke (CONNECT): a prospective cohort study protocol

Xian Chao,Jinjing Wang,Yiran Dong,Yirong Fang,Dawei Yin,Jie Wen,Peng Wang,Wen Sun

DOI: https://doi.org/10.1136/bmjopen-2023-077799

IF: 3.006

2024-01-30

BMJ Open

Abstract:Introduction Neuropsychiatric distubance is a common clinical manifestation in acute ischemic stroke. However, it is frequently overlooked by clinicians. This study aimed to explore the possible aetiology and pathogenesis of neuropsychiatric disturbances following ischaemic stroke (NDIS) from an anatomical and functional perspective with the help of neuroimaging methods. Method and analysis CONNECT is a prospective cohort study of neuroimaging and its functional outcome in NDIS. We aim to enrol a minimum of 300 individuals with first-ever stroke. The neuropsychological disturbances involved in this study include depression, anxiety disorder, headache, apathy, insomnia, fatigue and cognitive impairment. Using scales that have been shown to be effective in assessing the above symptoms, the NDIS evaluation battery requires at least 2 hours at baseline. Moreover, all patients will be required to complete 2 years of follow-up, during which the NDIS will be re-evaluated at 3 months, 12 months and 24 months by telephone and 6 months by outpatient interview after the index stroke. The primary outcome of our study is the incidence of NDIS at the 6-month mark. Secondary outcomes are related to the severity of NDIS as well as functional rehabilitation of patients. Functional imaging evaluation will be performed at baseline and 6-month follow-up using specific sequences including resting-state functional MRI, diffusion tensor imaging, T1-weighted imaging, T2-weighted imaging, diffusion-weighted imaging, arterial spin labelling, quantitative susceptibility mapping and fluid-attenuated inversion recovery imaging. In addition, we collect haematological information from patients to explore potential biological and genetic markers of NDIS through histological analysis. Ethics and dissemination The CONNECT Study was approved by the Ethics Review Committee of the First Hospital of the University of Science and Technology of China (2021-ky012) and written informed consent will be obtained from all participants. Results will be disseminated via a peer-reviewed journal. Trial registration number ChiCTR2100043886.

medicine, general & internal
Assessing the relationship between near-infrared spectroscopy-derived regional cerebral oxygenation and neurological dysfunction in critically ill adults: a prospective observational multicentre protocol, on behalf of the Canadian Critical Care Trials Group

Michael D Wood,Jasmine Khan,Kevin F H Lee,David M Maslove,John Muscedere,Miranda Hunt,Stephen H Scott,Andrew Day,Jill A Jacobson,Ian Ball,Marat Slessarev,Niamh O'Regan,Shane W English,Victoria McCredie,Michaël Chasse,Donald Griesdale,J Gordon Boyd,Niamh O’Regan

DOI: https://doi.org/10.1136/bmjopen-2019-029189

IF: 3.006

2019-06-01

BMJ Open

Abstract:Introduction Survivors of critical illness frequently exhibit acute and chronic neurological complications. The underlying aetiology of this dysfunction remains unknown but may be associated with cerebral ischaemia. This study will use near-infrared spectroscopy to non-invasively quantify regional cerebral oxygenation (rSO 2 ) to assess the association between poor rSO 2 during the first 72 hours of critical illness with delirium severity, as well as long-term sensorimotor and cognitive impairment among intensive care unit (ICU) survivors. Further, the physiological determinants of rSO 2 will be examined. Methods and analysis This multicentre prospective observational study will consider adult patients (≥18 years old) eligible for enrolment if within 24 hours of ICU admission, they require mechanical ventilation and/or vasopressor support. For 72 hours, rSO 2 will be continuously recorded, while vital signs (eg, heart rate) and peripheral oxygenation saturation will be concurrently captured with data monitoring software. Arterial and central venous gases will be sampled every 12 hours for the 72 hours recording period and will include: pH, PaO2, PaCO2, and haemoglobin concentration. Participants will be screened daily for delirium with the confusion assessment method (CAM)-ICU, whereas the brief-CAM will be used on the ward. At 3 and 12 months post-ICU discharge, neurological function will be assessed with the Repeatable Battery for the Assessment of Neuropsychological Status and KINARM sensorimotor and cognitive robot-based behavioural tasks. Ethics and dissemination The study protocol has been approved in Ontario by a central research ethics board (Clinical Trials Ontario); non-Ontario sites will obtain local ethics approval. The study will be conducted under the guidance of the Canadian Critical Care Trials Group (CCCTG) and the results of this study will be presented at national meetings of the CCCTG for internal peer review. Results will also be presented at national/international scientific conferences. On completion, the study findings will be submitted for publication in peer-reviewed journals. Trial registration number NCT03141619

medicine, general & internal
Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort study

Meghan R Hutch,Jiyeon Son,Trang T Le,Chuan Hong,Xuan Wang,Zahra Shakeri Hossein Abad,Michele Morris,Alba Gutiérrez-Sacristán,Jeffrey G Klann,Anastasia Spiridou,Ashley Batugo,Riccardo Bellazzi,Vincent Benoit,Clara-Lea Bonzel,William A Bryant,Lorenzo Chiudinelli,Kelly Cho,Priyam Das,Tomás González González,David A Hanauer,Darren W Henderson,Yuk-Lam Ho,Ne Hooi Will Loh,Adeline Makoudjou,Simran Makwana,Alberto Malovini,Bertrand Moal,Danielle L Mowery,Antoine Neuraz,Malarkodi Jebathilagam Samayamuthu,Fernando J Sanz Vidorreta,Emily R Schriver,Petra Schubert,Jeffery Talbert,Amelia L M Tan,Byorn W L Tan,Bryce W Q Tan,Valentina Tibollo,Patric Tippman,Guillaume Verdy,William Yuan,Paul Avillach,Nils Gehlenborg,Gilbert S Omenn,Consortium for Clinical Characterization of COVID-19 by EHR (4CE),Shyam Visweswaran,Tianxi Cai,Yuan Luo,Zongqi Xia

DOI: https://doi.org/10.1371/journal.pdig.0000484

2024-04-15

Abstract:Few studies examining the patient outcomes of concurrent neurological manifestations during acute COVID-19 leveraged multinational cohorts of adults and children or distinguished between central and peripheral nervous system (CNS vs. PNS) involvement. Using a federated multinational network in which local clinicians and informatics experts curated the electronic health records data, we evaluated the risk of prolonged hospitalization and mortality in hospitalized COVID-19 patients from 21 healthcare systems across 7 countries. For adults, we used a federated learning approach whereby we ran Cox proportional hazard models locally at each healthcare system and performed a meta-analysis on the aggregated results to estimate the overall risk of adverse outcomes across our geographically diverse populations. For children, we reported descriptive statistics separately due to their low frequency of neurological involvement and poor outcomes. Among the 106,229 hospitalized COVID-19 patients (104,031 patients ≥18 years; 2,198 patients <18 years, January 2020-October 2021), 15,101 (14%) had at least one CNS diagnosis, while 2,788 (3%) had at least one PNS diagnosis. After controlling for demographics and pre-existing conditions, adults with CNS involvement had longer hospital stay (11 versus 6 days) and greater risk of (Hazard Ratio = 1.78) and faster time to death (12 versus 24 days) than patients with no neurological condition (NNC) during acute COVID-19 hospitalization. Adults with PNS involvement also had longer hospital stay but lower risk of mortality than the NNC group. Although children had a low frequency of neurological involvement during COVID-19 hospitalization, a substantially higher proportion of children with CNS involvement died compared to those with NNC (6% vs 1%). Overall, patients with concurrent CNS manifestation during acute COVID-19 hospitalization faced greater risks for adverse clinical outcomes than patients without any neurological diagnosis. Our global informatics framework using a federated approach (versus a centralized data collection approach) has utility for clinical discovery beyond COVID-19.
PA 132, a new antibiotic. II. In vitro and in vivo studies.

A. R. English,T. Mcbride,J. Lynch

Abstract:
0301 Associations between sleep and cognitive function in patients with Neurological post-acute sequelae of SARS-CoV-2 infection

Kathryn Reid,Louis Ingram,Millenia Jimenez,Zachary Orban,Phyllis Zee,Igor Koralnik,Mathew Maas

DOI: https://doi.org/10.1093/sleep/zsad077.0301

IF: 6.313

2023-05-01

SLEEP

Abstract:Abstract Introduction Fatigue and sleep disturbance are among the most common neurological post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC). We tested the hypothesis that impaired sleep and disrupted rest-activity rhythms are associated with impaired cognitive performance and greater burden of self-reported Neuro-PASC symptoms. Methods Forty adults (mean age 45 years, 69% female, 15% hospitalized post COVID) recruited from the Neuro-COVID-19 Clinic at Northwestern Memorial Hospital. Patients were evaluated via clinical assessment/history, chart review, patient reported outcomes for symptom severity (PROMIS cognitive function, fatigue, sleep disturbance, anxiety, depression), cognitive performance tests (NIH Toolbox modules for processing speed, attention, executive function, working memory), and 7 days of wrist actigraphy with a sleep log. We tested associations between objective and subjective measures using Pearson’s correlation and difference from population normative data using Student’s t test. Results 39 participants provided sufficient data for analysis. The median number of discrete neurologic symptoms attributed to PASC was 6 with 87% reporting ≥4 neurologic symptoms. Fatigue, insomnia, and depression were common (~70% reporting each). Participants reported significant symptom burden in all PROMIS domains, and had measurably worse attention function along with borderline executive function, compared to population normative data (all p< 0.001 except executive cognition p=0.056). Actigraphy showed Neuro-PASC patients had lower sleep efficiency and greater sleep latency (both p< 0.001) but similar wakefulness after sleep onset (WASO) compared to age-matched population controls. Self-reported cognitive symptoms were correlated with severity of fatigue (p< 0.001), anxiety (p=0.05), and depression (p< 0.01), but not subjective sleep disturbance. There were no associations between actigraphy-measured sleep or rest-activity characteristics and self-reported symptoms. Patients with abnormal sleep characteristics (WASO, sleep efficiency, sleep latency) demonstrated impaired objective attention and executive function. Conclusion Neuro-PASC patients presenting to a post-COVID clinic have a significant burden of subjective mental health, sleep, fatigue and cognitive impairment symptoms, along with objectively abnormal cognitive performance and sleep, compared to population controls. Interventions to improve sleep could benefit cognitive performance. Prospective studies including larger populations of patients are needed to fully determine the interplay of sleep/circadian rhythm disruption on the cognitive function and quality of life in patients with PASC. Support (if any) Center for Circadian and Sleep Medicine

neurosciences,clinical neurology
Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction

Greta K. Wood,Brendan F. Sargent,Zain-Ul-Abideen Ahmad,Kukatharmini Tharmaratnam,Cordelia Dunai,Franklyn N. Egbe,Naomi H. Martin,Bethany Facer,Sophie L. Pendered,Henry C. Rogers,Christopher Hübel,Daniel J. van Wamelen,Richard A. I. Bethlehem,Valentina Giunchiglia,Peter J. Hellyer,William Trender,Gursharan Kalsi,Edward Needham,Ava Easton,Thomas A. Jackson,Colm Cunningham,Rachel Upthegrove,Thomas A. Pollak,Matthew Hotopf,Tom Solomon,Sarah L. Pett,Pamela J. Shaw,Nicholas Wood,Neil A. Harrison,Karla L. Miller,Peter Jezzard,Guy Williams,Eugene P. Duff,Steven Williams,Fernando Zelaya,Stephen M. Smith,Simon Keller,Matthew Broome,Nathalie Kingston,Masud Husain,Angela Vincent,John Bradley,Patrick Chinnery,David K. Menon,John P. Aggleton,Timothy R. Nicholson,John-Paul Taylor,Anthony S. David,Alan Carson,Ed Bullmore,Gerome Breen,Adam Hampshire,COVID-CNS Consortium,Ali M. Alam,Ammar Al-Chalabi,Christopher M. Allen,Jay Amin,Cherie Armour,Mark R. Baker,Suzanne Barrett,Neil Basu,Rahul Batra,Laura Benjamin,Alex Berry,Richard Bethlehem,Bethan Blackledge,Sarah A. Boardman,John R. Bradley,David P. Breen,Judith Breuer,Matthew R. Broome,Edward Bullmore,Matthew Butler,Hannah Castell,Jonathan Cavanagh,David Christmas,David M. Christmas,Jonathan R. I. Coleman,Alaistair Coles,Ceryce Collie,Nadine Cossette,David Cousins,Alastair Darby,Nicholas Davies,Sylviane Defres,Katherine C. Dodd,Alex Dregan,Eugene Duff,Mark A. Ellul,Nikos Evangelou,Peter M. Fernandes,Richard Francis,Ian Galea,Afagh Garjani,Lily George,Valentina Giunchiglia,Kiran Glen,Rebecca Gregory,Michael Griffiths,Victoria Grimbly,Alexander Grundmann,Savini Gunatilake,Shahd H. M. Hamid,Marc Hardwick,Jade D. Harris,Ewan Harrison,Paul J. Harrison,Monika Hartmann,Claire Hetherington,Orla Hilton,Julian Hiscox,Eva Maria Hodel,Angela E. Holland,Yun Huang,Stella Hughes,Sarosh Irani,Thomas M. Jenkins,Johan Kallberg Zvrskovec,Sandar Kyaw,Gabriella Lewis,James B. Lilleker,Michael P. Lunn,Claire L. MacIver,Daniel Madarshahian,Parisa Mansoori,Naomi Martin,Gavin McDonnell,Emily McGlinchey,Stephen McKeever,Ryan McIlwaine,Andrew M. McIntosh,Karla Miller,Dina Monssen,Christopher M. Morris,Ciaran Mulholland,Akshay Nair,Virginia Newcombe,Nathalie Nicholas,Timothy Nicholson,Ronan O’Malley,Obioma Orazulume,Marlies Ostermann,Alish Palmos,Arvind Patel,Sharon Peacock,Sophie Pendered,Thomas Pollak,Angela Roberts,Silvia Rota,Rustam Al-Shahi Salman,Merna Samuel,Brendan Sargent,Stephen J. Sawcer,Adam W. Seed,Scott Semple,Rajish S. K. Shil,Adam Sieradzki,Bhagteshwar Singh,Craig J. Smith,Jacqueline Smith,Stephen Smith,Leonie Taams,Arina Tamborska,Rhys H. Thomas,Emma Thomson,William Trender,Zain Ul-Abideen Ahmad,Jonathan Underwood,Tonny Veenith,Annalena Venneri,Daniel J. van Wamelen,Guy B. Williams,Sui Hsien Wong,Michael S. Zandi,Benedict D. Michael,Stella-Maria Paddick,E. Charles Leek

DOI: https://doi.org/10.1038/s41591-024-03309-8

IF: 82.9

2024-09-25

Nature Medicine

Abstract:The spectrum, pathophysiology, and recovery trajectory of persistent post-COVID-19 cognitive deficits are unknown, limiting our ability to develop prevention and treatment strategies. We report the one-year cognitive, serum biomarker, and neuroimaging findings from a prospective, national study of cognition in 351 COVID-19 patients who had required hospitalisation, compared to 2,927 normative matched controls. Cognitive deficits were global and associated with elevated brain injury markers, and reduced anterior cingulate cortex volume one year after COVID-19. The severity of the initial infective insult, post-acute psychiatric symptoms, and a history of encephalopathy were associated with greatest deficits. There was strong concordance between subjective and objective cognitive deficits. Longitudinal follow-up in 106 patients demonstrated a trend toward recovery. Together, these findings support the hypothesis that brain injury in moderate to severe COVID-19 may be immune-mediated, and should guide the development of therapeutic strategies.

biochemistry & molecular biology,cell biology,medicine, research & experimental
IC3 protocol: a longitudinal observational study of cognition after stroke using novel digital health technology

Dragos-Cristian Gruia,William Trender,Peter Hellyer,Soma Banerjee,Joseph Kwan,Henrik Zetterberg,Adam Hampshire,Fatemeh Geranmayeh,Gruia,D.-C.,Trender,W.,Hellyer,P.,Banerjee,S.,Kwan,J.,Zetterberg,H.,Hampshire,A.,Geranmayeh,F.

DOI: https://doi.org/10.1136/bmjopen-2023-076653

IF: 3.006

2023-11-25

BMJ Open

Abstract:Introduction Stroke is a major cause of death and disability worldwide, frequently resulting in persistent cognitive deficits among survivors. These deficits negatively impact recovery and therapy engagement, and their treatment is consistently rated as high priority by stakeholders and clinicians. Although clinical guidelines endorse cognitive screening for poststroke management, there is currently no gold-standard approach for identifying cognitive deficits after stroke, and clinical stroke services lack the capacity for long-term cognitive monitoring and care. Currently, available assessment tools are either not stroke-specific, not in-depth or lack scalability, leading to heterogeneity in patient assessments. Methods and analysis To address these challenges, a cost-effective, scalable and comprehensive screening tool is needed to provide a stroke-specific assessment of cognition. The current study presents such a novel digital tool, the Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3), designed to detect both domain-general and domain-specific cognitive deficits in patients after stroke with minimal input from a health professional. To ensure its reliability, we will use multiple validation approaches, and aim to recruit a large normative sample of age-matched, gender-matched and education-matched UK-based controls. Moreover, the IC3 assessment will be integrated within a larger prospective observational longitudinal clinical trial, where poststroke cognition will be examined in tandem with brain imaging and blood biomarkers to identify novel multimodal biomarkers of recovery after stroke. This study will enable deeper cognitive phenotyping of patients at a large scale, while identifying those with highest risk of progressive cognitive decline, as well as those with greatest potential for recovery. Ethics and dissemination This study has been approved by South West—Frenchay Research Ethics Committee (IRAS 299333) and authorised by the UK's Health Research Authority. Results from the study will be disseminated at conferences and within peer-reviewed journals. Trial registration number NCT05885295. Stage: Pre-results.

medicine, general & internal
Feasibility and reliability of online vs in-person cognitive testing in healthy older people

Sol Morrissey,Rachel Gillings,Michael Hornberger

DOI: https://doi.org/10.1371/journal.pone.0309006

IF: 3.7

2024-08-22

PLoS ONE

Abstract:Early evidence in using online cognitive assessments show that they could offer a feasible and resource-efficient alternative to in-person clinical assessments in evaluating cognitive performance, yet there is currently little understanding about how these assessments relate to traditional, in-person cognitive tests. In this preliminary study, we assess the feasibility and reliability of NeurOn, a novel online cognitive assessment tool. NeurOn measures various cognitive domains including processing speed, executive functioning, spatial working memory, episodic memory, attentional control, visuospatial functioning, and spatial orientation. Thirty-two participants (mean age: 70.19) completed two testing sessions, unsupervised online and in-person, one-week apart. Participants were randomised in the order of testing appointments. For both sessions, participants completed questionnaires prior to a cognitive assessment. Test-retest reliability and concurrent validity of the online cognitive battery was assessed using intraclass correlation coefficients (ICCs) and correlational analysis, respectively. This was conducted by comparing performance in repeated tasks across testing sessions as well as with traditional, in-person cognitive tests. Global cognition in the NeurOn battery moderately validated against MoCA performance, and the battery demonstrated moderate test-retest reliability. Concurrent validity was found only between the online and paper versions of the Trail Making Test -A, as well as global cognitive performance between online and in-person testing sessions. The NeurOn cognitive battery provides a promising tool for measuring cognitive performance online both longitudinally and across short retesting intervals within healthy older adults. When considering cost-effectiveness, flexible administration, and improved accessibility for wider populations, online cognitive assessments show promise for future screening of neurodegenerative diseases.

multidisciplinary sciences
COVID-19 pandemic & neurosciences in India- the CoINstudy: Impact of the pandemic on research related to the neurosciences

M.M. Samim,Makarand Pantoji,K.P. Divya,Harsh Deora,Abhinith Shashidhar,Jitupam Baishya,Divyani Garg,Arunmozhimaran Elavarasi,Bhavya Pahwa,Urvakhsh Meherwan Mehta,Sai Krishna Tikka,Vaibhav Wadwekar,Souvik Dubey,Kshiteeja Jain,Binukumar Bhaskarapillai,L.G. Viswanathan,Ajay Asranna

DOI: https://doi.org/10.25259/ijmr_30_23

2024-09-07

Abstract:Background & objectives We aimed to assess the impact of COVID-19-related disruptions on ongoing and future projects related to neuroscience research and young researchers in India. Methods We conducted a countrywide online survey using a structured, self-administered questionnaire involving medical trainees, post-doctoral fellows, PhD students, early career faculty members and basic neuroscience researchers. The purpose was to assess the impact of the COVID-19 pandemic on the respondents’ ongoing/planned research activities and capture their concerns related to future research. Results Five hundred and four valid responses were analyzed. More than three-fourths of the respondents were in their early careers – 64.1 per cent were resident doctors, and 19.8 per cent were early career consultants. Maximum responses were received from respondents working in neurology (228; 45.2%), followed by psychiatry (192; 38.1%) and neurosurgery (49; 9.7%). More than three-fourths [83.5%, 95% confidence interval (CI): 0.8–0.867] of the respondents reported that the pandemic had affected their research. About one-third of the respondents (171; 33.9%) reported delays in completing research studies. Respondents adapted to the pandemic’s circumstances by making methodological changes in their research (155; 30.8%). Most respondents (301; 59.6%) reported being diverted from their traditional work settings to COVID-19-related clinical services. Respondents conducting prospective studies and randomized controlled trials and those diverted to COVID-related services were significantly more likely to report the adverse research impact. Interpretation & conclusions In our survey, an overwhelming majority of the respondents reported that the pandemic adversely impacted their study. This trend was independent of sex, designation, and research output of individual subjects. The serious impact of the COVID-19 pandemic on neurosciences research warrants the attention and concerted efforts of the research supervisors, institutional heads, funding agencies and other stakeholders.

medicine, general & internal,immunology, research & experimental
Computer-based assessment of unilateral spatial neglect: A systematic review

Ioanna Giannakou,Dan Lin,David Punt

DOI: https://doi.org/10.3389/fnins.2022.912626

2022-08-19

Abstract:Background: To date, no gold standard exists for the assessment of unilateral spatial neglect (USN), a common post-stroke cognitive impairment, with limited sensitivity provided by currently used clinical assessments. Extensive research has shown that computer-based (CB) assessment can be more sensitive, but these have not been adopted by stroke services yet. Objective: We conducted a systematic review providing an overview of existing CB tests for USN to identify knowledge gaps and positive/negative aspects of different methods. This review also investigated the benefits and barriers of introducing CB assessment tasks to clinical settings and explored practical implications for optimizing future designs. Methodology: We included studies that investigated the efficacy of CB neglect assessment tasks compared to conventional methods in detecting USN for adults with brain damage. Study identification was conducted through electronic database searches (e.g., Scopus), using keywords and standardized terms combinations, without date limitation (last search: 08/06/2022). Literature review and study selection were based on prespecified inclusion criteria. The quality of studies was assessed with the quality assessment of diagnostic accuracy studies tool (Quadas-2). Data synthesis included a narrative synthesis, a table summarizing the evidence, and vote counting analysis based on a direction of effect plot. Results: A total of 28 studies met the eligibility criteria and were included in the review. According to our results, 13/28 studies explored CB versions of conventional tasks, 11/28 involved visual search tasks, and 5/28 other types of tasks. The vote counting analysis revealed that 17/28 studies found CB tasks had either equal or higher sensitivity than conventional methods and positive correlation with conventional methods (15/28 studies). Finally, 20/28 studies showed CB tasks effectively detected patients with USN within different patient groups and control groups (17/28). Conclusions: The findings of this review provide practical implications for the implementation of CB assessment in the future, offering important information to enhance a variety of methodological issues. The study adds to our understanding of using CB tasks for USN assessment, exploring their efficacy and benefits compared to conventional methods, and considers their adoption in clinical environments.
Persistent currents in a quantum ring: Effects of impurities and interactions.

Chakraborty,Pietiläinen

DOI: https://doi.org/10.1103/PHYSREVB.52.1932

1995-07-15

Abstract:

Letter Regarding "Scaphocapitate Arthrodesis for Treatment of Scapholunate Instability in Manual Workers"

Reliability of multi-site UK Biobank MRI brain phenotypes for the assessment of neuropsychiatric complications of SARS-CoV-2 infection: The COVID-CNS travelling heads study

Computerised cognitive assessment in patients with traumatic brain injury: an observational study of feasibility and sensitivity relative to established clinical scales

[The influence of intrahepatic transplantation of hepatocytes and insular cells on liver cirrhosis].

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Late results of valvoplasty for mitral regurgitation due to rupture of chordae tendineae of posterior cusp.

Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients

The National Institutes of Health COVID-19 Neuro Databank/Biobank: Creation and Evolution

Conducting an objective structured clinical examination under COVID-restricted conditions

Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

Neuroimaging of neuropsychological disturbances following ischaemic stroke (CONNECT): a prospective cohort study protocol

Assessing the relationship between near-infrared spectroscopy-derived regional cerebral oxygenation and neurological dysfunction in critically ill adults: a prospective observational multicentre protocol, on behalf of the Canadian Critical Care Trials Group

Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort study

PA 132, a new antibiotic. II. In vitro and in vivo studies.

0301 Associations between sleep and cognitive function in patients with Neurological post-acute sequelae of SARS-CoV-2 infection

Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction

IC3 protocol: a longitudinal observational study of cognition after stroke using novel digital health technology

Feasibility and reliability of online vs in-person cognitive testing in healthy older people

COVID-19 pandemic & neurosciences in India- the CoINstudy: Impact of the pandemic on research related to the neurosciences

Computer-based assessment of unilateral spatial neglect: A systematic review

Persistent currents in a quantum ring: Effects of impurities and interactions.